“…While pharmacotherapy for AUD is considered underutilized in the US despite clinical guidelines for first-line use in those with moderate to severe AUD ( Jonas et al, 2014 ; Mark, Kassed, Vandivort-Warren, Levit, & Kranzler, 2009 ; Reus et al, 2018 ), data specific to MSM remain scarce. In a cross-sectional study conducted by our research group, only 6.9% of MSM with hazardous alcohol use received medications for alcohol treatment ( Santos et al, 2018 ). Several studies have documented health care provider barriers to medication-assisted treatment, including inadequate knowledge of medication options and concerns about adherence, cost, efficacy, and side effects ( Lee, Kresina, Campopiano, Lubran, & Clark, 2015 ; Thomas, Wallack, Lee, McCarty, & Swift, 2003 ).…”